Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada

• Autores principales: Mtibaa M (Autor), Gupta S (Autor), Muthukumar M (Autor), Marvel J (Autor), Kaur H (Autor), Ishikawa R (Autor), Olivenstein R (Autor)
• Formato: Libro
• Publicado: Dove Medical Press, 2021-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Mondher Mtibaa,1 Subhajit Gupta,2 Madhusubramanian Muthukumar,2 Jessica Marvel,3 Harneet Kaur,2 Ryotaro Ishikawa,3 Ron Olivenstein4 1Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada; 2Novartis Healthcare Private Limited, Hyderabad, India; 3Novartis Pharma AG, Basel, Switzerland; 4McGill...